[ { "key": "SRBQGQZU", "version": 118, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/SRBQGQZU", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/SRBQGQZU", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "creatorSummary": "TB Diagnostics Market Analysis Consortium*", "parsedDate": "2016-03-01", "numChildren": 0 }, "data": { "key": "SRBQGQZU", "version": 118, "itemType": "journalArticle", "title": "Market assessment of tuberculosis diagnostics in India in 2013", "creators": [ { "creatorType": "author", "name": "TB Diagnostics Market Analysis Consortium*" } ], "abstractNote": "BACKGROUND: India represents a significant potential market for new tests. We assessed India's market for tuberculosis (TB) diagnostics in 2013.METHODS: Test volumes and unit costs were assessed for tuberculin tests, interferon-gamma release assays, sputum smear microscopy, serology, culture, speciation testing, nucleic-acid amplification tests (i.e., in-house polymerase chain reaction, Xpert® MTB/RIF, line-probe assays) and drug susceptibility testing. Data from the public sector were collected from the Revised National TB Control Programme reports. Private sector data were collected through a survey of private laboratories and practitioners. Data were also collected from manufacturers.RESULTS: In 2013, India's public sector performed 19.2 million tests, with a market value of US$22.9 million. The private sector performed 13.6 million tests, with a market value of US$60.4 million when prices charged to the patient were applied. The overall market was US$70.8 million when unit costs from the ingredient approach were used for the 32.8 million TB tests performed in the entire country. Smear microscopy was the most common test performed, accounting for 25% of the overall market value.CONCLUSION: India's estimated market value for TB diagnostics in 2013 was US$70.8 million. These data should be of relevance to test developers, donors and implementers.", "publicationTitle": "The International Journal of Tuberculosis and Lung Disease", "publisher": "", "place": "", "date": "2016-03-01", "volume": "20", "issue": "3", "section": "", "partNumber": "", "partTitle": "", "pages": "304-313", "series": "", "seriesTitle": "", "seriesText": "", "journalAbbreviation": "The International Journal of Tuberculosis and Lung Disease", "DOI": "10.5588/ijtld.15.0571", "citationKey": "", "url": "", "accessDate": "", "PMID": "", "PMCID": "", "ISSN": "", "archive": "", "archiveLocation": "", "shortTitle": "", "language": "", "libraryCatalog": "IngentaConnect", "callNumber": "", "rights": "", "extra": "", "tags": [ { "tag": "Costs", "type": 1 }, { "tag": "Diagnosis", "type": 1 }, { "tag": "Volumes", "type": 1 }, { "tag": "tests", "type": 1 } ], "collections": [ "IWVX2H3A" ], "relations": {}, "dateAdded": "2016-02-08T00:49:13Z", "dateModified": "2016-02-08T00:49:13Z" } }, { "key": "KEITSGJI", "version": 117, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/KEITSGJI", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/KEITSGJI", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/BFQXVV5N", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } } }, "data": { "key": "KEITSGJI", "version": 117, "parentItem": "BFQXVV5N", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2016-02-08T00:44:54Z", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S58.full", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "S58.html", "md5": "31e1e4728f9ee2ead3efe8a9e092f420", "mtime": 1454892294241, "tags": [], "relations": {}, "dateAdded": "2016-02-08T00:44:54Z", "dateModified": "2016-02-08T00:44:54Z" } }, { "key": "ZFM7445R", "version": 117, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/ZFM7445R", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/ZFM7445R", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/BFQXVV5N", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "numChildren": 0 }, "data": { "key": "ZFM7445R", "version": 117, "parentItem": "BFQXVV5N", "itemType": "attachment", "linkMode": "imported_url", "title": "Full Text PDF", "accessDate": "2016-02-08T00:44:51Z", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S58.full.pdf", "note": "", "contentType": "application/pdf", "charset": "", "filename": "Kik et al. - 2015 - Potential Market for Novel Tuberculosis Diagnostic.pdf", "md5": "e2e9eb13ac81c2828a1a8cfd299e756e", "mtime": 1454892293561, "tags": [], "relations": {}, "dateAdded": "2016-02-08T00:44:51Z", "dateModified": "2016-02-08T00:44:53Z" } }, { "key": "KW7P9RHP", "version": 116, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/KW7P9RHP", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/KW7P9RHP", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/BFQXVV5N", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } } }, "data": { "key": "KW7P9RHP", "version": 116, "parentItem": "BFQXVV5N", "itemType": "attachment", "linkMode": "linked_url", "title": "PubMed entry", "accessDate": "2016-02-08T00:44:51Z", "url": "http://www.ncbi.nlm.nih.gov/pubmed/25765107", "note": "", "contentType": "text/html", "charset": "", "tags": [], "relations": {}, "dateAdded": "2016-02-08T00:44:51Z", "dateModified": "2016-02-08T00:44:51Z" } }, { "key": "BFQXVV5N", "version": 116, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/BFQXVV5N", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/BFQXVV5N", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "creatorSummary": "Kik et al.", "parsedDate": "2015-04-01", "numChildren": 3 }, "data": { "key": "BFQXVV5N", "version": 116, "itemType": "journalArticle", "title": "Potential Market for Novel Tuberculosis Diagnostics: Worth the Investment?", "creators": [ { "creatorType": "author", "firstName": "Sandra V.", "lastName": "Kik" }, { "creatorType": "author", "firstName": "Claudia M.", "lastName": "Denkinger" }, { "creatorType": "author", "firstName": "Carole", "lastName": "Jefferson" }, { "creatorType": "author", "firstName": "Janet", "lastName": "Ginnard" }, { "creatorType": "author", "firstName": "Madhukar", "lastName": "Pai" } ], "abstractNote": "Background. The potential available market (PAM) for new diagnostics for tuberculosis that meet the specifications of the high-priority target product profiles (TPPs) is currently unknown.\nMethods. We estimated the PAM in 2020 in 4 high-burden countries (South Africa, Brazil, China, and India) for tests that meet the specifications outlined in the TPPs. The yearly PAM was estimated for the most likely application of each TPP.\nResults. In 2020 the PAM for all 4 countries together was estimated to be (1) 12M tests/year with a value of 48M-71M USD for a sputum smear-replacement test; (2) 16M tests/year with a value of 65M–97M USD for a biomarker test; (3) 18M tests/year with a value of 18M–35M USD for a triage test; (4) 12M tests/year with a value of 59M–2238M USD for a tuberculosis detection plus drug susceptibility test (DST) all-in-one or 1.5M tests/year for a DST that follows a positive tuberculosis detection test with a corresponding value of 75M–121M for both tuberculosis detection and DST.\nConclusions. Although there is a considerable potential market for novel tuberculosis diagnostics that fit the specification of the TPPs in the 4 high-burden countries, the actual market for an individual product remains uncertain.", "publicationTitle": "Journal of Infectious Diseases", "publisher": "", "place": "", "date": "04/01/2015", "volume": "211", "issue": "suppl 2", "section": "", "partNumber": "", "partTitle": "", "pages": "S58-S66", "series": "", "seriesTitle": "", "seriesText": "", "journalAbbreviation": "J Infect Dis.", "DOI": "10.1093/infdis/jiu817", "citationKey": "", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S58", "accessDate": "2016-02-08T00:44:51Z", "PMID": "", "PMCID": "", "ISSN": "0022-1899, 1537-6613", "archive": "", "archiveLocation": "", "shortTitle": "Potential Market for Novel Tuberculosis Diagnostics", "language": "en", "libraryCatalog": "jid.oxfordjournals.org", "callNumber": "", "rights": "", "extra": "PMID: 25765107", "tags": [ { "tag": "cost", "type": 1 }, { "tag": "diagnostics", "type": 1 }, { "tag": "market analysis", "type": 1 }, { "tag": "market projection", "type": 1 }, { "tag": "target product profiles", "type": 1 }, { "tag": "tests", "type": 1 }, { "tag": "tuberculosis", "type": 1 } ], "collections": [ "IWVX2H3A" ], "relations": {}, "dateAdded": "2016-02-08T00:44:51Z", "dateModified": "2016-02-08T00:44:51Z" } }, { "key": "XZNQBM75", "version": 115, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/XZNQBM75", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/XZNQBM75", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/HUHWBAXH", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } } }, "data": { "key": "XZNQBM75", "version": 115, "parentItem": "HUHWBAXH", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2016-02-07T23:08:27Z", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S39", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "S39.html", "md5": "348ce08ffbd532207e258f2481e05606", "mtime": 1454886508064, "tags": [], "relations": {}, "dateAdded": "2016-02-07T23:08:27Z", "dateModified": "2016-02-07T23:08:27Z" } }, { "key": "3DBDDS5R", "version": 115, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/3DBDDS5R", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/3DBDDS5R", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/HUHWBAXH", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "numChildren": 0 }, "data": { "key": "3DBDDS5R", "version": 115, "parentItem": "HUHWBAXH", "itemType": "attachment", "linkMode": "imported_url", "title": "Full Text PDF", "accessDate": "2016-02-07T23:08:23Z", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S39.full.pdf", "note": "", "contentType": "application/pdf", "charset": "", "filename": "Denkinger et al. - 2015 - Target Product Profile of a Molecular Drug-Suscept.pdf", "md5": "85cb2e396129012a928c4b13df49533f", "mtime": 1454886505402, "tags": [], "relations": {}, "dateAdded": "2016-02-07T23:08:23Z", "dateModified": "2016-02-07T23:08:25Z" } }, { "key": "HUHWBAXH", "version": 114, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/HUHWBAXH", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/HUHWBAXH", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "creatorSummary": "Denkinger et al.", "parsedDate": "2015-04-01", "numChildren": 3 }, "data": { "key": "HUHWBAXH", "version": 114, "itemType": "journalArticle", "title": "Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers", "creators": [ { "creatorType": "author", "firstName": "Claudia M.", "lastName": "Denkinger" }, { "creatorType": "author", "firstName": "David", "lastName": "Dolinger" }, { "creatorType": "author", "firstName": "Marco", "lastName": "Schito" }, { "creatorType": "author", "firstName": "William", "lastName": "Wells" }, { "creatorType": "author", "firstName": "Frank", "lastName": "Cobelens" }, { "creatorType": "author", "firstName": "Madhukar", "lastName": "Pai" }, { "creatorType": "author", "firstName": "Matteo", "lastName": "Zignol" }, { "creatorType": "author", "firstName": "Daniela Maria", "lastName": "Cirillo" }, { "creatorType": "author", "firstName": "David", "lastName": "Alland" }, { "creatorType": "author", "firstName": "Martina", "lastName": "Casenghi" }, { "creatorType": "author", "firstName": "Jim", "lastName": "Gallarda" }, { "creatorType": "author", "firstName": "Catharina C.", "lastName": "Boehme" }, { "creatorType": "author", "firstName": "Mark D.", "lastName": "Perkins" } ], "abstractNote": "Background. Current phenotypic testing for drug resistance in patients with tuberculosis is inadequate primarily with respect to turnaround time. Molecular tests hold the promise of an improved time to diagnosis.\nMethods. A target product profile for a molecular drug-susceptibility test (DST) was developed on the basis of a collaborative effort that included opinions gathered from researchers, clinicians, policy makers, and test developers on optimal clinical and operational characteristics in settings of intended use. In addition, the current diagnostic ecosystem and the diagnostic development landscape were mapped.\nResults. Molecular DSTs for detecting tuberculosis in microscopy centers should ideally evaluate for resistance to rifampin, fluoroquinolones, isoniazid, and pyrazinamide and enable the selection of the most appropriate treatment regimen. Performance characteristics of DSTs need to be optimized, but compromises can be made that depend on the trade-off between a false-positive result and a false-negative result. The operational requirements of a test will vary depending on the site of implementation. However, the most-important considerations pertain to quality control, maintenance and calibration, and the ability to export data.\nConclusion. This target product profile defines the needs as perceived by the tuberculosis stakeholder community and attempts to provide a means of communication with test developers to ensure that fit-for-purpose DSTs are being developed.", "publicationTitle": "Journal of Infectious Diseases", "publisher": "", "place": "", "date": "04/01/2015", "volume": "211", "issue": "suppl 2", "section": "", "partNumber": "", "partTitle": "", "pages": "S39-S49", "series": "", "seriesTitle": "", "seriesText": "", "journalAbbreviation": "J Infect Dis.", "DOI": "10.1093/infdis/jiu682", "citationKey": "", "url": "http://jid.oxfordjournals.org/content/211/suppl_2/S39", "accessDate": "2016-02-07T23:08:23Z", "PMID": "", "PMCID": "", "ISSN": "0022-1899, 1537-6613", "archive": "", "archiveLocation": "", "shortTitle": "", "language": "en", "libraryCatalog": "jid.oxfordjournals.org", "callNumber": "", "rights": "", "extra": "PMID: 25765105", "tags": [ { "tag": "diagnostics", "type": 1 }, { "tag": "molecular testing", "type": 1 }, { "tag": "point of care", "type": 1 }, { "tag": "tuberculosis", "type": 1 } ], "collections": [ "IWVX2H3A" ], "relations": {}, "dateAdded": "2016-02-07T23:08:23Z", "dateModified": "2016-02-07T23:08:23Z" } }, { "key": "PGMEGNXT", "version": 114, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/PGMEGNXT", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/PGMEGNXT", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/HUHWBAXH", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } } }, "data": { "key": "PGMEGNXT", "version": 114, "parentItem": "HUHWBAXH", "itemType": "attachment", "linkMode": "linked_url", "title": "PubMed entry", "accessDate": "2016-02-07T23:08:23Z", "url": "http://www.ncbi.nlm.nih.gov/pubmed/25765105", "note": "", "contentType": "text/html", "charset": "", "tags": [], "relations": {}, "dateAdded": "2016-02-07T23:08:23Z", "dateModified": "2016-02-07T23:08:23Z" } }, { "key": "ZQ29NSEW", "version": 113, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/ZQ29NSEW", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/ZQ29NSEW", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/DPGG3G47", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } } }, "data": { "key": "ZQ29NSEW", "version": 113, "parentItem": "DPGG3G47", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-04-26T22:28:56Z", "url": "http://www.hftb.org/heritage-news-picks/", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "heritage-news-picks.html", "md5": "feb3de9a4d77e092f4629a165ebcb240", "mtime": 1430087337040, "tags": [], "relations": {}, "dateAdded": "2015-04-26T22:28:56Z", "dateModified": "2015-04-26T22:28:56Z" } }, { "key": "DPGG3G47", "version": 112, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/DPGG3G47", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/DPGG3G47", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2317627, "username": "aarora14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/aarora14", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "DPGG3G47", "version": 112, "itemType": "webpage", "title": "Heritage News Picks", "creators": [], "abstractNote": "World’s first approved bionic eye to launch in U.S.- by Elizabeth Armstrong  Moore  July 2, 2013\nThe Argus II, which treats patients with the rare genetic condition known as retinitis pigmentosa, was approved by the FDA in February after more than 20 years in the making. Read article \n\n \n \n \n \nBionic eye promises vision for the blind – by Oliver Milman, theguardian.com, June 7, 2013\nMonash University is preparing to launch technology that ...", "websiteTitle": "Heritage for the Blind", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://www.hftb.org/heritage-news-picks/", "accessDate": "2015-04-26T22:28:54Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "3A9ACZQS" ], "relations": {}, "dateAdded": "2015-04-26T22:28:54Z", "dateModified": "2015-04-26T22:28:54Z" } }, { "key": "QH7DPRKI", "version": 111, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/QH7DPRKI", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/QH7DPRKI", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/G3DV5P65", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2054287, "username": "haacke", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/haacke", "type": "text/html" } } } }, "data": { "key": "QH7DPRKI", "version": 111, "parentItem": "G3DV5P65", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-04-20T04:40:03Z", "url": "http://jenniferfaris.com/what-does-a-person-with-retinitis-pigmentosa-rp-actually-see/", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "what-does-a-person-with-retinitis-pigmentosa-rp-actually-see.html", "md5": "191666922f9523553e50467d58bfe5eb", "mtime": 1429504803000, "tags": [], "relations": {}, "dateAdded": "2015-04-20T04:40:03Z", "dateModified": "2015-04-20T04:40:03Z" } }, { "key": "G3DV5P65", "version": 110, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/G3DV5P65", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/G3DV5P65", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2054287, "username": "haacke", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/haacke", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "G3DV5P65", "version": 110, "itemType": "blogPost", "title": "An explanation and video of Retinitis Pigmentosa", "creators": [], "abstractNote": "A brief explanation and video of what a person with Retinitis Pigmentosa might see as they lose their vision.", "blogTitle": "", "websiteType": "", "date": "", "DOI": "", "citationKey": "", "url": "http://jenniferfaris.com/what-does-a-person-with-retinitis-pigmentosa-rp-actually-see/", "accessDate": "2015-04-20T04:40:00Z", "ISSN": "", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [], "relations": {}, "dateAdded": "2015-04-20T04:40:00Z", "dateModified": "2015-04-20T04:40:00Z" } }, { "key": "ZN43Z5DK", "version": 109, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/ZN43Z5DK", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/ZN43Z5DK", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/DHQZBJCR", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } } }, "data": { "key": "ZN43Z5DK", "version": 109, "parentItem": "DHQZBJCR", "itemType": "attachment", "linkMode": "imported_url", "title": "Snapshot", "accessDate": "2015-04-20T01:01:44Z", "url": "https://www.caymanchem.com/app/template/Product.vm/catalog/16681", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "16681.html", "md5": "c11b9dda79e2297cbbd609175313247a", "mtime": 1429491706262, "tags": [], "relations": {}, "dateAdded": "2015-04-20T01:01:44Z", "dateModified": "2015-04-20T01:01:44Z" } }, { "key": "DHQZBJCR", "version": 108, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/DHQZBJCR", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/DHQZBJCR", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "DHQZBJCR", "version": 108, "itemType": "webpage", "title": "Unoprostone isopropyl ester (CAS 120373-24-2) || Cayman Chemical | Supplier", "creators": [], "abstractNote": "A prodrug form of the free acid analog of PGF2α . 1 mg · 5 mg · 10 mg · 50 mg", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "https://www.caymanchem.com/app/template/Product.vm/catalog/16681", "accessDate": "2015-04-20T01:01:37Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "KJSQBN7H" ], "relations": {}, "dateAdded": "2015-04-20T01:01:37Z", "dateModified": "2015-04-20T01:01:37Z" } }, { "key": "MDPVM9RJ", "version": 107, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/MDPVM9RJ", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/MDPVM9RJ", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/DGKAK6AS", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } } }, "data": { "key": "MDPVM9RJ", "version": 107, "parentItem": "DGKAK6AS", "itemType": "attachment", "linkMode": "imported_url", "title": "Neurotech", "accessDate": "2015-04-20T00:14:36Z", "url": "http://www.neurotechusa.com/news_press_releases/pr_2009-05-28.html", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "pr_2009-05-28.html", "md5": "81c62af17e5654feb8869e99bf36d97e", "mtime": 1429488874691, "tags": [], "relations": {}, "dateAdded": "2015-04-20T00:14:36Z", "dateModified": "2015-04-20T00:14:36Z" } }, { "key": "DGKAK6AS", "version": 106, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/DGKAK6AS", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/DGKAK6AS", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "DGKAK6AS", "version": 106, "itemType": "webpage", "title": "Neurotech", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://www.neurotechusa.com/news_press_releases/pr_2009-05-28.html", "accessDate": "2015-04-20T00:14:34Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "KJSQBN7H" ], "relations": {}, "dateAdded": "2015-04-20T00:14:34Z", "dateModified": "2015-04-20T00:14:34Z" } }, { "key": "DRFQT5J9", "version": 105, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/DRFQT5J9", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/DRFQT5J9", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/PTB4CC7I", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } } }, "data": { "key": "DRFQT5J9", "version": 105, "parentItem": "PTB4CC7I", "itemType": "attachment", "linkMode": "imported_url", "title": "Treatment For Retinal Degenerative Diseases | Neurotech Pharmaceuticals", "accessDate": "2015-04-19T23:47:15Z", "url": "http://www.neurotechusa.com/cntfrenexus.html", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "cntfrenexus.html", "md5": "924e14d0bcb5b5db5ed18f13c2c094ac", "mtime": 1429487234403, "tags": [], "relations": {}, "dateAdded": "2015-04-19T23:47:15Z", "dateModified": "2015-04-19T23:47:15Z" } }, { "key": "PTB4CC7I", "version": 104, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/PTB4CC7I", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/PTB4CC7I", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "PTB4CC7I", "version": 104, "itemType": "webpage", "title": "Treatment For Retinal Degenerative Diseases | Neurotech Pharmaceuticals", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://www.neurotechusa.com/cntfrenexus.html", "accessDate": "2015-04-19T23:47:13Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "KJSQBN7H" ], "relations": {}, "dateAdded": "2015-04-19T23:47:13Z", "dateModified": "2015-04-19T23:47:13Z" } }, { "key": "7WMA7NM3", "version": 103, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/7WMA7NM3", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/7WMA7NM3", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/CPZ8DUM9", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } } }, "data": { "key": "7WMA7NM3", "version": 103, "parentItem": "CPZ8DUM9", "itemType": "attachment", "linkMode": "imported_url", "title": "Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa - Full Text View - ClinicalTrials.gov", "accessDate": "2015-04-19T23:07:06Z", "url": "https://www.clinicaltrials.gov/ct2/show/NCT01786395?term=retinitis+pigmentosa&phase=2&rank=5", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "NCT01786395.html", "md5": "390d15edc1e07f340d7dade5a875fcbd", "mtime": 1429484824815, "tags": [], "relations": {}, "dateAdded": "2015-04-19T23:07:06Z", "dateModified": "2015-04-19T23:07:06Z" } }, { "key": "CPZ8DUM9", "version": 102, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/CPZ8DUM9", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/CPZ8DUM9", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "CPZ8DUM9", "version": 102, "itemType": "webpage", "title": "Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa - Full Text View - ClinicalTrials.gov", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "https://www.clinicaltrials.gov/ct2/show/NCT01786395?term=retinitis+pigmentosa&phase=2&rank=5", "accessDate": "2015-04-19T23:07:04Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "KJSQBN7H" ], "relations": {}, "dateAdded": "2015-04-19T23:07:04Z", "dateModified": "2015-04-19T23:07:04Z" } }, { "key": "B9IU6DUM", "version": 101, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/B9IU6DUM", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/B9IU6DUM", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2072689, "username": "rollervides", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/rollervides", "type": "text/html" } } }, "creatorSummary": "Birch et al.", "parsedDate": "2013", "numChildren": 0 }, "data": { "key": "B9IU6DUM", "version": 101, "itemType": "journalArticle", "title": "Randomized Trial of Ciliary Neurotrophic Factor Delivered by Encapsulated Cell Intraocular Implants for Retinitis Pigmentosa", "creators": [ { "creatorType": "author", "firstName": "David G.", "lastName": "Birch" }, { "creatorType": "author", "firstName": "Richard G.", "lastName": "Weleber" }, { "creatorType": "author", "firstName": "Jacque L.", "lastName": "Duncan" }, { "creatorType": "author", "firstName": "Glenn J.", "lastName": "Jaffe" }, { "creatorType": "author", "firstName": "Weng", "lastName": "Tao" } ], "abstractNote": "", "publicationTitle": "American Journal of Ophthalmology", "publisher": "", "place": "", "date": "8/2013", "volume": "156", "issue": "2", "section": "", "partNumber": "", "partTitle": "", "pages": "283-292.e1", "series": "", "seriesTitle": "", "seriesText": "", "journalAbbreviation": "", "DOI": "10.1016/j.ajo.2013.03.021", "citationKey": "", "url": "http://linkinghub.elsevier.com/retrieve/pii/S0002939413001852", "accessDate": "2015-04-19T23:06:38Z", "PMID": "", "PMCID": "", "ISSN": "00029394", "archive": "", "archiveLocation": "", "shortTitle": "", "language": "en", "libraryCatalog": "CrossRef", "callNumber": "", "rights": "", "extra": "", "tags": [], "collections": [ "KJSQBN7H" ], "relations": {}, "dateAdded": "2015-04-19T23:06:38Z", "dateModified": "2015-04-19T23:06:38Z" } }, { "key": "6K6NHQ4V", "version": 100, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/6K6NHQ4V", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/6K6NHQ4V", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/DZR2ZVNS", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2043325, "username": "c20s91", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/c20s91", "type": "text/html" } } } }, "data": { "key": "6K6NHQ4V", "version": 100, "parentItem": "DZR2ZVNS", "itemType": "attachment", "linkMode": "imported_url", "title": "Press Releases - Second Sight Medical Products, Inc.", "accessDate": "2015-04-19T20:59:47Z", "url": "http://investors.secondsight.com/releases.cfm", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "releases.html", "md5": "43f4030640b26c3985bf88a5642bbd8d", "mtime": 1429477186264, "tags": [], "relations": {}, "dateAdded": "2015-04-19T20:59:47Z", "dateModified": "2015-04-19T20:59:47Z" } }, { "key": "DZR2ZVNS", "version": 99, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/DZR2ZVNS", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/DZR2ZVNS", "type": "text/html" } }, "meta": { "createdByUser": { "id": 2043325, "username": "c20s91", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/c20s91", "type": "text/html" } } }, "numChildren": 1 }, "data": { "key": "DZR2ZVNS", "version": 99, "itemType": "webpage", "title": "Press Releases - Second Sight Medical Products, Inc.", "creators": [], "abstractNote": "", "websiteTitle": "", "websiteType": "", "date": "", "publisher": "", "place": "", "DOI": "", "citationKey": "", "url": "http://investors.secondsight.com/releases.cfm", "accessDate": "2015-04-19T20:59:45Z", "shortTitle": "", "language": "", "rights": "", "extra": "", "tags": [], "collections": [ "QFMII6SV" ], "relations": {}, "dateAdded": "2015-04-19T20:59:45Z", "dateModified": "2015-04-19T20:59:45Z" } }, { "key": "JGNBXPW5", "version": 97, "library": { "type": "group", "id": 339331, "name": "Argus II Retinal Prosthesis Systems", "links": { "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems", "type": "text/html" } } }, "links": { "self": { "href": "https://api.zotero.org/groups/339331/items/JGNBXPW5", "type": "application/json" }, "alternate": { "href": "https://www.zotero.org/groups/argus_ii_retinal_prosthesis_systems/items/JGNBXPW5", "type": "text/html" }, "up": { "href": "https://api.zotero.org/groups/339331/items/KIRPEA4F", "type": "application/json" } }, "meta": { "createdByUser": { "id": 2044547, "username": "Baxler14", "name": "", "links": { "alternate": { "href": "https://www.zotero.org/baxler14", "type": "text/html" } } } }, "data": { "key": "JGNBXPW5", "version": 97, "parentItem": "KIRPEA4F", "itemType": "attachment", "linkMode": "imported_url", "title": "ScienceDirect Snapshot", "accessDate": "2015-04-16T23:45:36Z", "url": "http://www.sciencedirect.com/science/article/pii/S0140673606697407", "note": "", "contentType": "text/html", "charset": "utf-8", "filename": "S0140673606697407.html", "md5": "fbf04663a7ffe496dcbe06f074853758", "mtime": 1429227936000, "tags": [], "relations": {}, "dateAdded": "2015-04-16T23:45:36Z", "dateModified": "2015-04-16T23:45:36Z" } } ]